It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Primary cilia are key sensory organelles whose dysfunction leads to ciliopathy disorders such as Bardet-Biedl syndrome (BBS). Retinal degeneration is common in ciliopathies, since the outer segments (OSs) of photoreceptors are highly specialized primary cilia. BBS1, encoded by the most commonly mutated BBS-associated gene, is part of the BBSome protein complex. Using a bbs1 zebrafish mutant, we show that retinal development and photoreceptor differentiation are unaffected by Bbs1-loss, supported by an initially unaffected transcriptome. Quantitative proteomics and lipidomics on samples enriched for isolated OSs show that Bbs1 is required for BBSome-complex stability and that Bbs1-loss leads to accumulation of membrane-associated proteins in OSs, with enrichment in proteins involved in lipid homeostasis. Disruption of the tightly regulated OS lipid composition with increased OS cholesterol content are paralleled by early functional visual deficits, which precede progressive OS morphological anomalies. Our findings identify a role for Bbs1/BBSome in OS lipid homeostasis, suggesting a pathomechanism underlying retinal degeneration in BBS.
Primary cilia are key sensory organelles whose dysfunction leads to ciliopathy disorders such as Bardet-Biedl syndrome (BBS). Here they identify a role for Bbs1 in lipid homeostasis of photoreceptor outer segments in zebrafish, which may contribute to vision loss in patients with Bardet-Biedl syndrome.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details








1 University of Zurich, Institute of Medical Genetics, Schlieren, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650); University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
2 Karlsruhe Institute of Technology, Institute of Biological and Chemical Systems (IBCS-BIP), Karlsruhe, Germany (GRID:grid.7892.4) (ISNI:0000 0001 0075 5874)
3 University Hospital Zurich, Institute of Clinical Chemistry, Zurich, Switzerland (GRID:grid.412004.3) (ISNI:0000 0004 0478 9977)
4 University of Zurich, Department of Molecular Life Sciences, Zurich, Switzerland (GRID:grid.7400.3) (ISNI:0000 0004 1937 0650)
5 Karlsruhe Institute of Technology, Institute of Biological and Chemical Systems (IBCS-BIP), Karlsruhe, Germany (GRID:grid.7892.4) (ISNI:0000 0001 0075 5874); University of Heidelberg, Center of Organismal Studies, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)